Evidence map›Paper›PMID 28472233›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.

Damon J A Toth, Karim Khader, Rachel B Slayton, Alexander J Kallen, Adi V Gundlapalli, Justin J O'Hagan, Anthony E Fiore, Michael A Rubin, John A Jernigan, Matthew H Samore

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Distinct Origins and Transmission Pathways ofJournal of clinical microbiology · 2023
    Article
  15. Article
  16. Challenges in Forecasting Antimicrobial Resistance.Emerging infectious diseases · 2023
    Review
  17. Risk factors for colonization with multidrug-resistant Gram-negative bacteria andFrontiers in cellular and infection microbiology · 2023
    Article
  18. Identifying asymptomatic spreaders of antimicrobial-resistant pathogens in hospital settings.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Article
  20. Epidemiology and Transmission of Carbapenemase-ProducingAntimicrobial agents and chemotherapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Damon J A TothDepartment of Veterans Affairs, Salt Lake City Health Care System, Utah.
Karim KhaderDepartment of Veterans Affairs, Salt Lake City Health Care System, Utah.
Rachel B SlaytonDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Alexander J KallenDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Adi V GundlapalliDepartment of Veterans Affairs, Salt Lake City Health Care System, Utah.
Justin J O'HaganDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Anthony E FioreDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Michael A RubinDepartment of Veterans Affairs, Salt Lake City Health Care System, Utah.
John A JerniganDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Matthew H SamoreDepartment of Veterans Affairs, Salt Lake City Health Care System, Utah.

Funding

HSRD VA I50 HX001240Intramural CDC HHS CC999999NCEZID CDC HHS U54 CK000456
6 · The paper itself

Abstract

backgroundCarbapenem-resistant Enterobacteriaceae (CRE) are high-priority bacterial pathogens targeted for efforts to decrease transmissions and infections in healthcare facilities. Some regions have experienced CRE outbreaks that were likely amplified by frequent transmission in long-term acute care hospitals (LTACHs). Planning and funding of intervention efforts focused on LTACHs is one proposed strategy to contain outbreaks; however, the potential regional benefits of such efforts are unclear.

methodsWe designed an agent-based simulation model of patients in a regional network of 10 healthcare facilities including 1 LTACH, 3 short-stay acute care hospitals (ACHs), and 6 nursing homes (NHs). The model was calibrated to achieve realistic patient flow and CRE transmission and detection rates. We then simulated the initiation of an entirely LTACH-focused intervention in a previously CRE-free region, including active surveillance for CRE carriers and enhanced isolation of identified carriers.

resultsWhen initiating the intervention at the first clinical CRE detection in the LTACH, cumulative CRE transmissions over 5 years across all 10 facilities were reduced by 79%-93% compared to no-intervention simulations. This result was robust to changing assumptions for transmission within non-LTACH facilities and flow of patients from the LTACH. Delaying the intervention until the 20th CRE detection resulted in substantial delays in achieving optimal regional prevalence, while still reducing transmissions by 60%-79% over 5 years.

conclusionsFocusing intervention efforts on LTACHs is potentially a highly efficient strategy for reducing CRE transmissions across an entire region, particularly when implemented as early as possible in an emerging outbreak.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeComputer SimulationEnterobacteriaceae InfectionsAnti-Bacterial AgentsCross InfectionDisease OutbreaksHealth FacilitiesHumansAnti-Bacterial Agentsactive surveillancecarbapenem-resistant Enterobacteriaceaelong-term acute care hospitalmathematical modeltransmission

Identifiers

PMID28472233
PMCPMC12231108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.